Cell Mogrify Ltd., of Cambridge, U.K., said it was awarded $555,000 from Innovate UK to support the application of its bioinformatic platform to move three regenerative cell therapy candidates into preclinical development, with potential applications in wound healing and oncology immunotherapy.